Target intelligence / Profile preview

Family with sequence similarity 90 member A20 (FAM90A20)

Target
FAM90A20
Molecular classification
Other (Putative Gene, Pseudogene or Uncharacterized Protein)
01

Overview

FAM90A20 (family with sequence similarity 90 member A20) appears to be either a pseudogene or a putative/uncharacterized protein in the human genome. Scientific literature and protein databases do not ascribe any confirmed biological function, molecular activity, or disease association to FAM90A20. It is *not* part of the Fam20 secretory pathway kinase family (which includes FAM20A, FAM20B, and FAM20C—genes involved in extracellular protein phosphorylation, biomineralization, and rare genetic diseases)[1][2][3]. No evidence supports FAM90A20 as a therapeutic target, and it is not associated with known drugs, mechanisms of action, or biomarker use. The abundance of alternate names reflects its listing as a putative gene/protein in genomic references, rather than as a characterized target. **Note:** FAM90A20 is often confused with FAM20A, a genuine pseudokinase involved in critical secretory phosphorylation processes; these are distinct. If you are seeking information about FAM20A or other thoroughly studied Fam20 proteins, refer specifically to those gene names[1][2][3].

Other names
FAM90A20Protein FAM90A20FAM90A20PProtein FAM90A20PFAM90A20 pseudogeneputative protein FAM90A20putative protein FAM90A20Pfamily with sequence similarity 90 member A20

Beyond the preview

Go deeper on Family with sequence similarity 90 member A20 (FAM90A20).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Family with sequence similarity 90 member A20 (FAM90A20).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call